RECRUITING

Using Facebook to Support Opioid Recovery Among American Indian Women

Talk to us

Conditions

Opioid Use DisorderAmerican Indian or Alaska NativeInternet-based InterventionCommunity-based Participatory ResearchMinnesotaEthnic and Racial MinoritiesWomen's Health

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to find out whether a Facebook group will help Native women in recovery from opioid use.

Official Title

Facebook Intervention for Preventing Opioid Relapse Among American Indian Women: Wiidookaage'Win Pilot Preparatory Study (Aim 2)

Quick Facts

Study Start:2023-10-16
Study Completion:2024-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05995886

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. AIAN person based on self-reported race/ethnicity
  2. 2. Gender identity as a woman
  3. 3. At least 18 years of age with no upper age limit
  4. 4. Resides in Minnesota
  5. 5. Meets criteria for OUD based on the DSM-5 Checklist (American Psychiatric Association, 2013)
  6. 6. Self-reports at least one month of abstinence from opioid use based on TLFB interview and negative urine opiate screen
  7. 7. Current use of MOUD
  8. 8. Is comfortable speaking and reading English
  9. 9. Has an existing Facebook account or willing to set one up
  10. 10. Is willing and able to participate in the Facebook intervention for 3 months
  11. 11. Has access to broadband internet on a mobile phone/computer/tablet at any location
  12. 12. Is willing and able to travel to a community clinic in Minneapolis, Minnesota for the UDS or is willing to and able to complete a virtual Zoom UDS visit.
  13. 13. Provides written informed consent
  1. 1. Self-reports current suicidality based on the Concise Heath Risk Tracking scale
  2. 2. Participated in prior study phases (Aim 1 formative work) of NIDA CTN-0123

Contacts and Locations

Study Contact

Ashley Brown
CONTACT
1-833-880-2600
wiidookaagewin@mayo.edu

Principal Investigator

Christi A Patten, PhD
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic
Rochester, Minnesota, 55901
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Christi A Patten, PhD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-16
Study Completion Date2024-12

Study Record Updates

Study Start Date2023-10-16
Study Completion Date2024-12

Terms related to this study

Keywords Provided by Researchers

  • American Indian or Alaska Native
  • Internet-based Intervention
  • Community-based Participatory Research
  • Minnesota
  • Ethnic and Racial Minorities
  • Women's Health

Additional Relevant MeSH Terms

  • Opioid Use Disorder